Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time to vent.
Mr. Pohl should be talking to brokerages, analysts, and others who can attract buyers to the stock. We are EXTREMELY undervalued here... if you'll recall Pohl spoke to a brokerage before the run to $2.20... he should be doing the same now. Wall Street, for the most part, knows nothing of this stock. Mr. Pohl's DUTY, his FIDUCIARY RESPONSIBILITY, is to INCREASE the pps. He's doing a MISERABLE job of it in light of the reaction (or lack thereof) to our latest PR.
Share
New Message
Please login to post a reply